Hadassah

Hyperpolarizing Phosphates to Diagnose Disease: a Hadassah World First

Wednesday, Aug 30 2017

What can the phosphorus in your blood tell you about your health?

Researchers in the Hadassah Medical Organization’s imaging department have developed a world-first noninvasive diagnostic method to measure phosphate levels in the body’s tissues that can alert them to the presence of diseases such as cancer.

Their discovery appears in the August 24, 2017 online issue of Nature Communications.

The novel procedure is being hailed as a breakthrough because it is currently impossible to test the acidity level in the tissues of the human body without performing an invasive procedure. In addition, examining a tissue sample for this purpose is not a diagnostic option because body tissue changes within seconds. With this new diagnostic tool, however, researchers can determine the level of acidity which can vary, for example, when there is a cancerous tumor present.

Dr. Rachel Katz-Brull, who heads Hadassah’s research team, explains: “This is a diagnostic tool related to the metabolic function of the cells in a tumor or other suspicious tissue. Such a measure could allow, for example, a more precise identification of a tumor as malignant or benign and help test the efficacy of treatment.”

With this new technology, a patient could be saved from invasive procedures such as a biopsy to determine whether a tumor is cancerous. Instead, via this high-tech MRI imaging, the phosphate is caused to “shine” more than 10,000 times brighter, enabling the researchers to see the nucleus of the phosphorous-containing cell. And this clarity is achieved without injecting radioactive materials into the patient. Hadassah is one of the few medical centers in the world that is equipped with this technology.

Dr. Katz-Brull completed postdoctoral research at Harvard University and Beth Israel-Deaconess Hospital in Massachusetts. When she returned to Israel, she established the Center for Hyperpolarized MRI Molecular Imaging in Hadassah’s radiology department.

Read more in the Jerusalem Post.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Friday, Aug 17 2018

Hadassah Mourns the Loss of Aretha Franklin and Urges Greater Awareness of Diagnosis and Treatment of Pancreatic Cancer

Sadly, the “queen of soul” Aretha Franklin passed away yesterday at age 76, due to an advanced pancreatic neuroendocrine tumor (pancreatic NET or PNET).

READ MORE ›
alt_text

Wednesday, Aug 15 2018

Hadassah Hospital’s Bone Marrow Transplant Department Receives International Acclaim

In a first for Israel, Hadassah Medical Organization’s Bone Marrow Transplantation and Cancer Immunotherapy Department has recently received full accreditation by the Joint Accreditation Committee ISCT-EUROPE & EBMT (JACIE), Europe’s only official accreditation body in the field.

READ MORE ›
alt_text

Tuesday, Aug 14 2018

Hadassah Hospital Helps Educate Mikvah Attendants To Bolster Women’s Health

After a woman emerges from the ritual bath (mikveh) and wraps herself in a towel, says mikveh attendant Daniella Salomon, “I keep an eye out” for anything unusual.

READ MORE ›
alt_text

Tuesday, Aug 7 2018

American Medical Attaché and Consulate Nurse Tour Hadassah Hospital Ein Kerem

Jennifer Kmiecinski, Medical Attaché to the Consulate General of the United States in Israel, visited Hadassah Hospital Ein Kerem earlier this month to assess the level of health care available to American personnel serving in Israel.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More